Does the IL23R rs11209026 GG genotype increase susceptibility to Th17-mediated intestinal inflammation?

The IL23R rs11209026 polymorphism is one of the most significant genetic factors associated with susceptibility to inflammatory bowel disease (IBD). This variant involves a nucleotide substitution that changes the amino acid at position 381 of the Interleukin-23 receptor from arginine (Arg) to glutamine (Gln).

Clinical and effectiveness evidence

Large-scale genome-wide association studies (GWAS) and meta-analyses consistently identify the GG genotype (Arg/Arg) as the common "risk" variant for both Crohn's disease and ulcerative colitis.

• Disease Risk: In a landmark study (Duerr et al., 2006), the alternative A allele (Gln) was shown to provide strong protection against Crohn's disease, with an odds ratio of approximately 0.26. This implies that individuals with the GG genotype possess the baseline susceptibility required for the manifestation of Th17-driven intestinal pathology.
• Population Prevalence: The G allele is the major allele in most populations; therefore, the GG genotype represents the standard functional state of the IL-23 receptor in the general population, whereas carriers of the A allele have significantly reduced risk.

Mechanistic explanations

The rs11209026 polymorphism directly affects the functional capacity of the IL-23/Th17 signaling axis, which is central to mucosal immunity and chronic inflammation.

• Receptor Signaling: The GG genotype encodes a fully functional IL-23 receptor. Upon binding of the IL-23 ligand, this receptor efficiently activates the JAK2 and STAT3 signaling pathways.
• Th17 Differentiation: Phosphorylated STAT3 translocates to the nucleus to upregulate RORγt, the master transcription factor for Th17 cells. This promotes the expansion and survival of Th17 cells, which secrete pro-inflammatory cytokines such as IL-17A, IL-17F, and IL-22.
• Contrasting Variants: In contrast, the protective A allele (Gln381) leads to decreased cell-surface expression of the receptor and impaired STAT3 activation. This reduces the Th17-mediated inflammatory response, explaining why the GG genotype is associated with higher susceptibility to intestinal inflammation.

Bottom line

The IL23R rs11209026 GG genotype is firmly associated with increased susceptibility to Th17-mediated intestinal inflammation because it supports maximal IL-23 receptor signaling and Th17 cell activity, whereas the alternative A allele variant acts as a potent protective factor.